↓ Skip to main content

Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease

Overview of attention for article published in Frontiers in Pharmacology, September 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy
1 policy source
twitter
2 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease
Published in
Frontiers in Pharmacology, September 2018
DOI 10.3389/fphar.2018.01074
Pubmed ID
Authors

Paola Galozzi, Chiara Baggio, Sara Bindoli, Francesca Oliviero, Paolo Sfriso

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Other 8 22%
Student > Bachelor 7 19%
Student > Doctoral Student 2 5%
Student > Ph. D. Student 2 5%
Researcher 2 5%
Other 6 16%
Unknown 10 27%
Readers by discipline Count As %
Medicine and Dentistry 12 32%
Pharmacology, Toxicology and Pharmaceutical Science 4 11%
Agricultural and Biological Sciences 3 8%
Biochemistry, Genetics and Molecular Biology 2 5%
Environmental Science 1 3%
Other 4 11%
Unknown 11 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2023.
All research outputs
#7,059,720
of 23,567,572 outputs
Outputs from Frontiers in Pharmacology
#2,952
of 17,186 outputs
Outputs of similar age
#122,184
of 342,732 outputs
Outputs of similar age from Frontiers in Pharmacology
#64
of 389 outputs
Altmetric has tracked 23,567,572 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 17,186 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,732 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 389 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.